Target intelligence / Profile preview

Lipoxygenase homology domain-containing protein 1 (LOXHD1) (LOXHD1)

Target
LOXHD1
Molecular classification
PLAT-domain containing protein, Scaffold protein
01

Overview

Lipoxygenase homology domain-containing protein 1 (LOXHD1) is a scaffold protein primarily expressed in the mechanosensory hair cells of the inner ear. It is composed of 15 polycystin-1, lipoxygenase, and alpha-toxin (PLAT) domains, which are thought to mediate membrane-protein or protein-protein interactions critical for the structural integrity of stereocilia. LOXHD1 is localized along the length of the stereocilia and plays a vital role in the mechanotransduction process, which converts sound-induced vibrations into electrical signals for the brain. Mutations in the LOXHD1 gene are a leading cause of autosomal recessive non-syndromic hearing loss, specifically the DFNB77 phenotype, which can present as congenital or late-onset progressive deafness. Due to its essential role in auditory function and the monogenic nature of DFNB77, LOXHD1 has become a primary target for gene therapy. Current therapeutic approaches focus on using adeno-associated virus (AAV) vectors to deliver a wild-type copy of the LOXHD1 gene directly into the cochlea to restore or preserve hearing in affected individuals.

Other names
DFNB77LH2D1Lipoxygenase homology domain 1PLAT domain-containing protein 1
02

Mechanism of action

Gene replacement therapy to restore functional LOXHD1 protein in mechanosensory hair cells

03

Biological functions

Auditory perceptionMechanotransductionMaintenance of hair cell stereociliaProtein-protein interactionSensory perception of sound
04

Disease associations

Autosomal recessive non-syndromic deafness 77 (DFNB77)Hereditary hearing lossAge-related hearing loss
05

Safety considerations

AAV vector immunogenicityOff-target genetic integrationSurgical risks of inner ear delivery (e.g., round window membrane injection)Overexpression toxicity in hair cells
06

Interacting drugs

AAV-LOXHD1 gene therapy (investigational)
07

Biomarkers

LOXHD1 gene mutationsHearing threshold shifts (audiometry)

Beyond the preview

Go deeper on Lipoxygenase homology domain-containing protein 1 (LOXHD1) (LOXHD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipoxygenase homology domain-containing protein 1 (LOXHD1) (LOXHD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call